UCSF, Mount Sinai and the Pasteur Institute unveil their first results in vitro for drug repositioning against COVID19 in Nature

UCSF, Mount Sinai and the Pasteur Institute unveil their first results in vitro for drug repositioning against COVID19 in NatureFirst QBI-Pasteur symposium at UCSF in March 2019, from left to right: N. Krogan, Director of QBI, M. Ott, UCSF, O. Scwhartz, Pasteur, C. D'Enfert, Scientific Director of Pasteur.

French-American collaboration continues in the fight against COVID19 with University of California in San Francisco, the Mount Sinai Hospital in New York and the Institut Pasteur in Paris.

French-American collaboration continues in the fight against COVID19. The international alliance formed by the University of California in San Francisco, the Mount Sinai Hospital in New York and the Institut Pasteur in Paris unveiled today the first results of its in vitro experiments on drug repositioning, a strategy that can lead to a rapid deployment of drugs that already exist against the epidemic.

Read the press release here.

Consult the article published in Nature here.

To support this collaboration, visit this page.

To find out more about this collaboration:

Interview with Nevan Krogan (QBI-UCSF) and the Consul General of France in San Francisco:

image_pdfimage_print